PAXMEDICA, INC.

(PXMD)
SummaryNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

PaxMedica, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021

01/04/2022 | 05:11pm EDT

PaxMedica, Inc. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported net loss was USD 16.46 million compared to USD 3.45 million a year ago. Basic loss per share from continuing operations was USD 2.5 compared to USD 0.85 a year ago.


© S&P Capital IQ 2022
All news about PAXMEDICA, INC.
04/25PaxMedica, Inc. announced a financing transaction
CI
01/07PaxMedica, Inc. Plans to Initiate Phase 1B Study for PAX-101 in Patients with Long COVI..
CI
01/04PaxMedica, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
2021Paxmedica, Inc. Presents Clinical Data and New Analyses from A Phase 2 Trial of Pax-101..
CI
2021PaxMedica to Present Data from its Recent Phase 2 Trial of PAX-101 (IV suramin) in Chil..
CI
2021PaxMedica Announces Positive Results from Phase 2 Trial of PAX-101 (IV suramin) in Chil..
CI
2020PaxMedica, Inc. announced that it has received $3 million in funding
CI
2020PaxMedica, Inc. announced that it expects to receive $3 million in funding
CI
2020PaxMedica, Inc. has filed an IPO in the amount of $18.4575 million.
CI
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -7,83 M - -
Net cash 2020 0,51 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 59,1 M 59,1 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 5
Free-Float 26,3%
Income Statement Evolution
Managers and Directors
Joseph Lucchese Chief Financial Officer
Zachary Rome Chief Operating Officer & Director
Karen T. Dawes Independent Director
Paul Kevin Wotton Independent Director
Robert F. Apple Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PAXMEDICA, INC.0.00%59
MODERNA, INC.-48.00%52 528
LONZA GROUP AG-27.13%42 896
IQVIA HOLDINGS INC.-28.41%38 232
SEAGEN INC.-13.67%24 569
ICON PUBLIC LIMITED COMPANY-30.17%17 581